Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis - Wikidata - wikimedia - TriplyDB

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

http://www.wikidata.org/entity/Q37036566

about

Heterogeneity in tuberculosis pathology, microenvironments and therapeutic responses New insights into TB physiology suggest untapped therapeutic opportunities Pipeline of drugs for related diseases: tuberculosis Interception of host angiogenic signalling limits mycobacterial growth.Latent tuberculosis infection: myths, models, and molecular mechanisms In vitro and in vivo activities of the nitroimidazole TBA-354 against Mycobacterium tuberculosis Comparative efficacy and acceptability of five anti-tubercular drugs in treatment of multidrug resistant tuberculosis: a network meta-analysis.Adventures within the speckled band: heterogeneity, angiogenesis, and balanced inflammation in the tuberculous granuloma.Targeting dormant bacilli to fight tuberculosis.Antibiotic-induced neurotoxicity.PET/CT imaging correlates with treatment outcome in patients with multidrug-resistant tuberculosis.Nonclinical models for antituberculosis drug development: a landscape analysis.Emerging drugs and alternative possibilities in the treatment of tuberculosis.Targeting Phenotypically Tolerant Mycobacterium tuberculosis.News on therapeutic management of MDR-tuberculosis: a literature review.NOS2-deficient mice with hypoxic necrotizing lung lesions predict outcomes of tuberculosis chemotherapy in humans.Antitubercular Nitroimidazoles Revisited: Synthesis and Activity of the Authentic 3-Nitro Isomer of Pretomanid.RepTB: a gene ontology based drug repurposing approach for tuberculosis.Identification of protective postexposure mycobacterial vaccine antigens using an immunosuppression-based reactivation model in the zebrafish.Ultrasensitive electrochemical determination of metronidazole based on polydopamine/carboxylic multi-walled carbon nanotubes nanocomposites modified GCE.Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial

P2860

Q26823503-FC5F80C7-34E5-4941-B7C3-68C3DFA6D2B4 Q28388477-C85CA715-EDE0-4C15-A39D-7F0A9EFCB6B0 Q28818217-C693F90E-A1D6-4B17-BC5C-996CB652D652 Q30619346-D3CE4BFF-7B14-4FD0-AA52-234C80E8C185 Q34297816-45778945-6D40-4FD6-B5C3-506F69ABB67D Q34922070-24354C22-EA7C-4CCA-A15F-175B0F0126E4 Q35559180-888AFFB3-643D-468C-AFC8-41624BE669D8 Q36439790-E5D14441-CEBC-4A73-BD8B-A7A479858B72 Q38173371-778E3561-FE25-4E30-B940-68CBD41553C2 Q38263096-393A61D3-3784-491F-BCFF-095372E22F73 Q38393463-FCC3DC5B-8C71-4062-B3F7-18415C23F6E4 Q38502294-123F8736-7CAC-4679-B90E-A5D50C108C8E Q38724073-0904A0B1-5923-4A73-A13F-1F5B6064B1CE Q39149038-BF033C6F-EB50-4D06-B273-FA77542DCD3B Q39398924-80122BC5-D239-4A5F-A5C5-8574D885B7BD Q40087530-6C76A614-8D7D-4B4B-BE6F-2826632247FD Q47772704-674AB137-26E9-4CF6-9E75-4E58815E3310 Q54203363-06C1C592-C399-445F-BD9E-895D37078F23 Q54246706-AF180325-329B-4E71-AA27-184149B6D8FA Q55223008-B2462CB3-A16E-43EA-BCB5-F6C6CBDA8F2C Q57276328-79A0BD34-BBB2-4FFF-BCF8-CEB01813E601

P2860

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

http://www.wikidata.org/entity/Q37036566

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 03 June 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

@en

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis.

@nl

type

label

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

@en

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis.

@nl

prefLabel

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

@en

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis.

@nl

P1433

Q37036566-117E49FB-B23A-4579-83B0-2A91BF3CF0C8

P1476

Q37036566-8510457E-DCF4-4F53-94BB-7677E849889A

P2093

Q37036566-0A854FDC-AB6F-4983-BD4A-581022B0A98B

Q37036566-164F3544-F5F7-42EB-9615-A798AFBD54BE

Q37036566-25053903-9D18-42E2-AB36-C822B9297C3E

Q37036566-5034E68F-E682-40B8-A7F3-B0442BE30DB9

Q37036566-509F6E9C-0DA0-4433-9819-FAC7B697BE59

Q37036566-52D64A1B-79E5-48FE-8B34-C4DE782E513F

Q37036566-5BDA47F8-7819-48EE-A47F-2543B350CC3D

Q37036566-5DDC79AD-A1F5-4B1E-A9FD-6DD49822A561

Q37036566-6F930BCB-236F-4211-AB7B-2F0DBF8EC682

Q37036566-7E0D64AB-F503-4117-8D55-AA20E07F2D6D

P2860

Q37036566-0454ABD8-149E-457C-916A-2109758344DA

Q37036566-0E845A17-3900-4760-AA74-9097B4D57D4A

Q37036566-119B56C3-5D10-4450-9F1E-AB6BBC6ECA1C

Q37036566-1EB6F8EA-A7E9-4E0A-85BB-077B794E0A16

Q37036566-366DACA3-09AA-4D44-ADD7-FE540A5A251B

Q37036566-3FE741C4-0060-43A9-BBBD-F15FC8647D24

Q37036566-44D8E7F0-E2A7-4059-8C9B-532509019C86

Q37036566-4C0FB279-006A-405C-AB59-C8DCA9B8E772

Q37036566-4D4E8490-658C-4A79-AA84-201750A84A1B

Q37036566-53768CC0-8F5E-429B-AF02-D5659CA47FAD

P304

Q37036566-A68D8D07-118C-4E98-8F25-49F09F2AE78D

P31

Q37036566-91F350D6-B540-4FD6-9C8E-590E10D0B868

P356

Q37036566-01FCD29D-A836-40EF-9D27-958FF2B1C60F

P407

Q37036566-D180C964-75BC-45E4-9B77-DBF52A3291ED

P433

Q37036566-8AA63212-0BEC-4BDF-857D-341BF000A3E1

P478

Q37036566-79221F14-BA12-4F16-B901-7F1F15976197

P50

Q37036566-B01E9D7E-F16C-49FB-B02B-D398D5D98841

Q37036566-B9F81BD9-735B-435C-9243-633762F52A75

Q37036566-EF1E0344-21D6-4044-B5B8-5960C13B65F8

P577

Q37036566-B4F341A3-4FF6-4A06-A1AE-4A6294F97CDD

P698

Q37036566-8A8C3816-4C64-426D-A33B-84D2591F7F42

P921

Q37036566-7F336B1D-E98D-426E-8C71-9861E0636F1E

Q37036566-A79AC10F-8407-4814-AF3A-51093DE4F2AC

P932

Q37036566-92B1AF1C-63A3-420C-8394-67E2FF43B12A

P356

P1433

Antimicrobial Agents and Chemotherapy

P1476

Efficacy and safety of metronidazole for pulmonary multidrug-resistant tuberculosis

@en

P2093

Boyoung Jin

http://www.w3.org/2001/XMLSchema#string

Cheon Tae Kim

http://www.w3.org/2001/XMLSchema#string

Doosoo Jeon

http://www.w3.org/2001/XMLSchema#string

James M Mountz

http://www.w3.org/2001/XMLSchema#string

Jong Doo Lee

http://www.w3.org/2001/XMLSchema#string

Jongseok Lee

http://www.w3.org/2001/XMLSchema#string

Lisa C Goldfeder

http://www.w3.org/2001/XMLSchema#string

Lori E Dodd

http://www.w3.org/2001/XMLSchema#string

Matthew W Carroll

http://www.w3.org/2001/XMLSchema#string

Myungsun Lee

http://www.w3.org/2001/XMLSchema#string

P2860

Nitroimidazoles for the treatment of TB: past, present and future

Delamanid for multidrug-resistant pulmonary tuberculosis

Metronidazole neuropathy

Persistent metronidazole-induced peripheral neuropathy

Metronidazole therapy in mice infected with tuberculosis

An in vitro model for sequential study of shiftdown of Mycobacterium tuberculosis through two stages of nonreplicating persistence

Cytological and transcript analyses reveal fat and lazy persister-like bacilli in tuberculous sputum

Induction of a novel class of diacylglycerol acyltransferases and triacylglycerol accumulation in Mycobacterium tuberculosis as it goes into a dormancy-like state in culture

Nonreplicating persistence of mycobacterium tuberculosis

Tuberculous granulomas are hypoxic in guinea pigs, rabbits, and nonhuman primates

P304

3903-3909

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/AAC.00753-13

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

57

http://www.w3.org/2001/XMLSchema#string

P50

Clifton E Barry

P577

2013-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23733467

http://www.w3.org/2001/XMLSchema#string

P921

Akafuba bulwadde

multiple drug resistance

P932

3719751

http://www.w3.org/2001/XMLSchema#string